Prevalence and management of severe asthma in the Nordic countries : findings from the NORDSTAR cohort

dc.contributor.authorHansen, Susanne
dc.contributor.authorvon Bülow, Anna
dc.contributor.authorSandin, Patrik
dc.contributor.authorErnstsson, Olivia
dc.contributor.authorJanson, Christer
dc.contributor.authorLehtimäki, Lauri
dc.contributor.authorKankaanranta, Hannu
dc.contributor.authorUlrik, Charlotte
dc.contributor.authorAarli, Bernt Bøgvald
dc.contributor.authorFues Wahl, Hanna
dc.contributor.authorGeale, Kirk
dc.contributor.authorTang, Sheila Tuyet
dc.contributor.authorWolf, Maija
dc.contributor.authorLarsen, Tom
dc.contributor.authorAltraja, Alan
dc.contributor.authorBackman, Helena
dc.contributor.authorKilpeläinen, Maritta
dc.contributor.authorViinanen, Arja
dc.contributor.authorLúðvíksdóttir, Dóra
dc.contributor.authorKauppi, Paula
dc.contributor.authorSverrild, Asger
dc.contributor.authorLehmann, Sverre
dc.contributor.authorBacker, Vibeke
dc.contributor.authorYasinska, Valentyna
dc.contributor.authorSkjold, Tina
dc.contributor.authorKarjalainen, Jussi
dc.contributor.authorBossios, Apostolos
dc.contributor.authorPorsbjerg, Celeste
dc.contributor.departmentFaculty of Medicine
dc.date.accessioned2025-11-20T09:13:18Z
dc.date.available2025-11-20T09:13:18Z
dc.date.issued2023-03-01
dc.descriptionFunding Information: Support statement: This study is presented on the behalf of the NORDSTAR study group. NORDSTAR is a pan-Nordic multiparty research collaboration platform governed by the Nordic Severe Asthma Network (NSAN). Data management and analyses are conducted by Quantify Research. NORDSTAR is financially supported by Novartis and Sanofi & Regeneron Pharmaceuticals. Funding information for this article has been deposited with the Crossref Funder Registry. Publisher Copyright: © The authors 2023.en
dc.description.abstractBACKGROUND: Real-life evidence on prevalence and management of severe asthma is limited. Nationwide population registries across the Nordic countries provide unique opportunities to describe prevalence and management patterns of severe asthma at population level. In nationwide register data from Sweden, Norway and Finland, we examined the prevalence of severe asthma and the proportion of severe asthma patients being managed in specialist care. METHODS: This is a cross-sectional study based on the Nordic Dataset for Asthma Research (NORDSTAR) research collaboration platform. We identified patients with severe asthma in adults (aged ≥18 years) and in children (aged 6-17 years) in 2018 according to the European Respiratory Society/American Thoracic Society definition. Patients managed in specialist care were those with an asthma-related specialist outpatient contact (only available in Sweden and Finland). RESULTS: Overall, we identified 598 242 patients with current asthma in Sweden, Norway and Finland in 2018. Among those, the prevalence of severe asthma was 3.5%, 5.4% and 5.2% in adults and 0.4%, 1.0%, and 0.3% in children in Sweden, Norway and Finland, respectively. In Sweden and Finland, 37% and 40% of adult patients with severe asthma and two or more exacerbations, respectively, were managed in specialist care; in children the numbers were 56% and 41%, respectively. CONCLUSION: In three Nordic countries, population-based nationwide data demonstrated similar prevalence of severe asthma. In children, severe asthma was a rare condition. Notably, a large proportion of patients with severe asthma were not managed by a respiratory specialist, suggesting the need for increased recognition of severe asthma in primary care.en
dc.description.versionPeer revieweden
dc.format.extent1163813
dc.format.extent
dc.identifier.citationHansen, S, von Bülow, A, Sandin, P, Ernstsson, O, Janson, C, Lehtimäki, L, Kankaanranta, H, Ulrik, C, Aarli, B B, Fues Wahl, H, Geale, K, Tang, S T, Wolf, M, Larsen, T, Altraja, A, Backman, H, Kilpeläinen, M, Viinanen, A, Lúðvíksdóttir, D, Kauppi, P, Sverrild, A, Lehmann, S, Backer, V, Yasinska, V, Skjold, T, Karjalainen, J, Bossios, A & Porsbjerg, C 2023, 'Prevalence and management of severe asthma in the Nordic countries : findings from the NORDSTAR cohort', ERJ Open Research, vol. 9, no. 2, 00687-2022. https://doi.org/10.1183/23120541.00687-2022en
dc.identifier.doi10.1183/23120541.00687-2022
dc.identifier.issn2312-0541
dc.identifier.other120948253
dc.identifier.other1c2b122b-3f48-4d57-a8d4-9073870642fb
dc.identifier.other37020835
dc.identifier.otherPubMedCentral: PMC10068510
dc.identifier.other85153731153
dc.identifier.otherunpaywall: 10.1183/23120541.00687-2022
dc.identifier.urihttps://hdl.handle.net/20.500.11815/7165
dc.language.isoen
dc.relation.ispartofseriesERJ Open Research; 9(2)en
dc.relation.urlhttps://www.scopus.com/pages/publications/85153731153en
dc.rightsinfo:eu-repo/semantics/openAccessen
dc.subjectPulmonary and Respiratory Medicineen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.titlePrevalence and management of severe asthma in the Nordic countries : findings from the NORDSTAR cohorten
dc.type/dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/articleen

Skrár

Original bundle

Niðurstöður 1 - 1 af 1
Nafn:
00687_2022.full.pdf
Stærð:
1.11 MB
Snið:
Adobe Portable Document Format

Undirflokkur